Search Results 111-120 of 16231 for Cefotaxime

  1. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

  2. A Study of Using Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients with Acute Myeloid Leukemia Who Are Undergoing Chemotherapy - Mayo Clinic

    This randomized phase III trial studies caspofungin acetate to see how it works compared to fluconazole in preventing invasive fungal infections in patients ...

  3. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

    RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide and dexamethasone, work in different ways to stop the growth of cancer cells, either by killing ...

  4. https://www.mayoclinic.org/chinese_organization_concepts.xml

  5. A Study of ASTX660 Alone or Combined with ASTX727 in Subjects with Relapsed/Refractory Acute Myeloid Leukemia (AML) - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and efficacy of ASTX660 when given alone and in combination ...

  6. Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

    About this study. This randomized phase II trial studies how well ATR kinase inhibitor M6620 (M6620) and gemcitabine hydrochloride work compared to standard ...

  7. https://www.mayoclinic.org/spanish_patient_consumer_web.xml

  8. Frontotemporal dementia - Doctors and departments - Mayo Clinic

    Mayo Clinic staff actively research frontotemporal dementia and related conditions. Researchers study risk factors, causes, diagnostic techniques and treatment ...

  9. Device Evaluation for Point of Care Anticoagulation Testing - Mayo Clinic

    About this study. The purpose of this study is: To Evaluate and validate the Roche Coaguchek XS Plus analyzer at MCA to replace the ITC Hemochron Jr.

  10. Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...